FIGO released first trimester preeclampsia screening guidance that provides recommendations for assessing risk based not only on clinical history and findings, but also biomarkers. FIGO calls for universal screening for preeclampsia
All pregnant women should be screened for preterm PE during early pregnancy by the first‐trimester combined test with maternal risk factors and biomarkers as a one‐step procedure
Best Combined Test (high risk defined as ≥ 1 in 100)
Note: Calculator is open access and available in the ‘Learn More – Primary Sources’ below
Systolic BP ≥140 mm Hg and/or diastolic BP ≥90 mm Hg on at least two occasions measured 4 hours apart in previously normotensive women, with ≥1 of the following new‐onset conditions ≥20 weeks
…biomarkers and ultrasonography cannot accurately predict preeclampsia and should remain investigational
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.